Citigroup’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.52M | Buy |
|
|||||
|
2025
Q2 | $1.28M | Sell |
|
|||||
|
2025
Q1 | $1.9M | Sell |
|
|||||
|
2024
Q4 | $1.96M | Buy |
|
|||||
|
2024
Q3 | $1.64M | Buy |
|
|||||
|
2024
Q2 | $1.05M | Sell |
|
|||||
|
2024
Q1 | $1.26M | Buy |
|
|||||
|
2023
Q4 | $788K | Buy |
|
|||||
|
2023
Q3 | $497K | Sell |
|
|||||
|
2023
Q2 | $575K | Buy |
|
|||||
|
2023
Q1 | $250K | Sell |
|
|||||
|
2022
Q4 | $321K | Buy |
|
|||||
|
2022
Q3 | $223K | Sell |
|
|||||
|
2022
Q2 | $232K | Sell |
|
|||||
|
2022
Q1 | $352K | Buy |
|
|||||
|
2021
Q4 | $398K | Buy |
|
|||||
|
2021
Q3 | $196K | Sell |
|
|||||
|
2021
Q2 | $231K | Buy |
|
|||||
|
2021
Q1 | $53K | Sell |
|
|||||
|
2020
Q4 | $84K | Buy |
|
|||||
|
2020
Q3 | $42K | Sell |
|
|||||
|
2020
Q2 | $162K | Buy |
|
|||||
|
2020
Q1 | $181K | Sell |
|
|||||
|
2019
Q4 | $384K | Sell |
|
|||||
|
2019
Q3 | $6.12M | Buy |
|
|||||
|
2019
Q2 | $1.17M | Buy |
|
|||||
|
2019
Q1 | $184K | Sell |
|
|||||
|
2018
Q4 | $1.81M | Sell |
|
|||||
|
2018
Q3 | $2.35M | Buy |
|
|||||
|
2018
Q2 | $1.4M | Sell |
|
|||||
|
2018
Q1 | $1.75M | Buy |
|
|||||
|
2017
Q4 | $1.67M | Sell |
|
|||||
|
2017
Q3 | $1.47M | Buy |
|
|||||
|
2017
Q2 | $720K | Sell |
|
|||||
|
2017
Q1 | $899K | Sell |
|
|||||
|
2016
Q4 | $1.41M | Buy |
|
|||||
|
2016
Q3 | $600K | Buy |
|
|||||
|
2016
Q2 | $286K | Sell |
|
|||||
|
2016
Q1 | $476K | Buy |
|
|||||
|
2015
Q4 | $19K | Sell |
|
|||||
|
2015
Q3 | $37K | Buy |
|
|||||
|
2015
Q2 | $46K | Sell |
|
|||||
|
2015
Q1 | $657K | Sell |
|
|||||
|
2014
Q4 | $729K | Buy |
|
|||||
|
2014
Q3 | $7K | Buy |
|
|||||
|
2014
Q2 | $4K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $2K | Buy |
|